TTP-ICG fluorescent probe for carcinoma, transitional cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Aug 2026: Trial started, NCT07848854
  2. 30 Sep 2026: Trial registered, NCT07848854

The trials

NCT07848854: Trop2-Targeted NIR-II Fluorescent Probe for Identifying Bladder Cancer in Ex Vivo Bladder Samples

State
Under way
Phase
Phase 2
People
30 planned
Started
1 Aug 2026
Primary completion
30 Jul 2027
Arms
TTP-ICG ex-vivo rapid incubation fluorescence imaging
Results
None posted
  1. 1 Aug 2026: Trial started
  2. 30 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.